OverviewSuggest Edit

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The Сompany's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.

TypePublic
Founded2003
HQBoston, MA, US
Websiteradiuspharm.com
Employee Ratings2.9

Latest Updates

Employees (est.) (Dec 2019)383(-3%)
Job Openings19
Revenue (FY, 2020)$238.6 M(+1871%)
Share Price (Mar 2021)$20.2
Cybersecurity ratingBMore

Key People/Management at Radius Health

Sal Grausso

Sal Grausso

Chief Commercial Officer
Bruce Mitlak

Bruce Mitlak

Chief Medical Officer, Head of Discovery Science
Kelly Martin

Kelly Martin

President and Chief Executive Officer, Director
Averi Price

Averi Price

General Counsel and Chief Compliance Officer
Chhaya Shah

Chhaya Shah

Chief Business Officer
Show more

Radius Health Office Locations

Radius Health has offices in Boston and Wayne
Boston, MA, US (HQ)
22 Boston Wharf Rd 7th Floor
Wayne, PA, US
CrossPoint at Valley Forge, 550 Swedesford Rd #370
Show all (2)

Radius Health Financials and Metrics

Radius Health Revenue

Radius Health's revenue was reported to be $238.65 m in FY, 2020
USD

Revenue (FY, 2020)

238.6m

Net income (FY, 2020)

(109.2m)

EBIT (FY, 2020)

(82.4m)

Market capitalization (30-Mar-2021)

945.4m

Closing stock price (30-Mar-2021)

20.2

Cash (31-Dec-2020)

91.4m

EV

884.9m
Radius Health's current market capitalization is $945.4 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

12.1m238.6m

Cost of goods sold

7.6m

General and administrative expense

5.3m9.5m6.8m13.7m30.8m77.5m186.7m184.2m152.7m144.2m

R&D expense

36.2m55.0m60.5m45.7m68.3m107.4m83.1m99.9m116.8m159.7m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

980.0k3.5m14.5m47.9m50.1m50.4m

Cost of goods sold

105.0k

Gross profit

875.0k

Gross profit Margin, %

89%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

25.1m18.7m12.3m28.5m159.7m258.6m118.6m59.3m69.9m91.4m

Accounts Receivable

28.3m4.4m16.8m23.3m20.3m

Prepaid Expenses

6.7m2.5m334.0k2.1m7.0m5.2m13.8m12.1m13.3m

Inventories

2.3m4.4m6.2m5.3m9.2m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

25.3m19.9m18.0m18.8m20.4m13.4m24.8m19.5m29.6m48.4m16.5m34.8m44.4m168.7m104.4m120.6m198.6m174.6m135.1m446.9m56.1m51.4m62.0m71.5m66.9m88.9m40.7m56.2m81.8m

Accounts Receivable

1.2m11.7m8.0m11.0m12.9m20.8m23.6m21.5m30.4m17.9m21.2m

Prepaid Expenses

3.4m3.3m8.4m6.0m4.2m1.2m1.4m242.0k2.3m1.8m1.4m2.5m3.1m4.5m2.8m5.2m3.7m6.5m5.9m7.8m6.4m6.5m10.1m12.4m8.2m15.2m9.2m7.9m11.3m

Inventories

1.6m3.1m5.4m6.2m5.5m5.6m5.2m4.9m6.0m5.9m7.5m
USDQ2, 2011

Financial Leverage

-0.3 x
Show all financial metrics

Radius Health Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Radius Health Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Radius Health Online and Social Media Presence

Embed Graph

Radius Health News and Updates

Radius Health Provides Update on Abaloparatide

BOSTON, March 24, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) provided an update on the abaloparatide asset including regulatory progress as well as U.S. commercial activity.

Radius Health, Inc. Announces $175 Million Financing Transaction

BOSTON, March 03, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS), today announced that the Company has entered into amended and restated credit facilities in the aggregate principal amount of $175 million, consisting of a $150 million term loan, which inclu…

Radius Health, Inc.: Fourth Quarter and Full Year Results

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS), today reported its financial results for the fourth quarter ended December 31, 2020 as well as full year 2020 results. In addition, a number of brief business updates are included.

Radius Health to Present at 10th Annual SVB Leerink Global Healthcare Conference

BOSTON, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that it will provide a corporate update at the 10th Annual SVB Leerink Global Healthcare Conference at 10:40 a.m. ET on Thursday, February 25, 2021.

Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021

BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter financial results on Thursday, February 25, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m. ET that day to discuss the results and provid…

Radius Health, Inc. Provides Abaloparatide Business Update

BOSTON, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) provided a business update on the abaloparatide global business. Progress was made, and continues to be made, across the following areas.
Show more

Radius Health Blogs

January 2021 Investor Presentation

January 2021 Investor Presentation Brian.Hoenig@n… Thu, 01/14/2021 - 15:40 January 2021 Investor Presentation Display "add to calendar" true Event Type Other Corporate Event Categories Default Calendar …

Radius Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 06, 2021 (GLOBE NEWSWIRE) -- Radius Health , Inc. (Nasdaq: RDUS), today announced that Kelly Martin, President and CEO will present a virtual corporate update at the 39 th  Annual J.P. Morgan Healthcare Conference on Wednesday, January 13 at 9:10 a.m. EST .

Radius Health, Inc.: Third Quarter 2020 Operating Results

TYMLOS ®   U.S. net sales of $50 million with 8% year-over-year growth; Total Revenues of $78 million Q3 commercial pivot to focus on high risk fracture segment is gaining traction: Net New U.S. Patients increased by 7+% in September 2020 vs. previous 3-month moving average and 10 +% in October vs.

Radius Health to Announce Third Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, November 5, 2020

WALTHAM, Mass. , Oct. 20, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its third quarter financial results on Thursday, November 5, 2020 . The Company will host a conference call and live audio webcast at 8:30 a.m.

Peter A. Schwartzman Joins Radius Health, Inc.

Schwartzman joins the newly formed Capital, Strategy, & Transactions Group WALTHAM, Mass. , Oct. 06, 2020 (GLOBE NEWSWIRE) -- Radius Health , Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced that Peter A. Schwartzman is joining the company as Vice President in the newly formed

Sean Murphy

Sean Murphy Brian.Hoenig@n… Mon, 10/05/2020 - 09:33 Member of the Audit Committee Sean Murphy View Biography
Show more

Radius Health Frequently Asked Questions

  • When was Radius Health founded?

    Radius Health was founded in 2003.

  • Who are Radius Health key executives?

    Radius Health's key executives are Sal Grausso, Bruce Mitlak and Kelly Martin.

  • How many employees does Radius Health have?

    Radius Health has 383 employees.

  • What is Radius Health revenue?

    Latest Radius Health annual revenue is $238.6 m.

  • What is Radius Health revenue per employee?

    Latest Radius Health revenue per employee is $623.1 k.

  • Who are Radius Health competitors?

    Competitors of Radius Health include Alembic Pharmaceuticals, EMS Pharma and Biocon.

  • Where is Radius Health headquarters?

    Radius Health headquarters is located at 22 Boston Wharf Rd 7th Floor, Boston.

  • Where are Radius Health offices?

    Radius Health has offices in Boston and Wayne.

  • How many offices does Radius Health have?

    Radius Health has 2 offices.